Comment on

• Dual antiplatelet therapy after drug-eluting stents--how long to treat?

  Colombo A, Chieffo A. Colombo A, et al. N Engl J Med. 2014 Dec 4;371(23):2225-6. doi: 10.1056/NEJMe1413297. Epub 2014 Nov 16. N Engl J Med. 2014. PMID: 25399657 No abstract available.
• Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents.

  Mauri L, Kereiakes DJ, Yeh RW, Driscoll-Shempp P, Cutlip DE, Steg PG, Normand SL, Braunwald E, Wiviott SD, Cohen DJ, Holmes DR Jr, Krucoff MW, Hermiller J, Dauerman HL, Simon DI, Kandzari DE, Garratt KN, Lee DP, Pow TK, Ver Lee P, Rinaldi MJ, Massaro JM; DAPT Study Investigators. Mauri L, et al. N Engl J Med. 2014 Dec 4;371(23):2155-66. doi: 10.1056/NEJMoa1409312. Epub 2014 Nov 16. N Engl J Med. 2014. PMID: 25399658 Free PMC article. Clinical Trial.
• Evaluating the generalizability of a large streamlined cardiovascular trial: comparing hospitals and patients in the dual antiplatelet therapy study versus the National Cardiovascular Data Registry.

  Yeh RW, Czarny MJ, Normand SL, Kereiakes DJ, Holmes DR Jr, Brindis RG, Weaver WD, Rumsfeld JS, Roe MT, Kim S, Driscoll-Shempp P, Mauri L. Yeh RW, et al. Circ Cardiovasc Qual Outcomes. 2015 Jan;8(1):96-102. doi: 10.1161/CIRCOUTCOMES.114.001239. Epub 2014 Nov 16. Circ Cardiovasc Qual Outcomes. 2015. PMID: 25399847 Free PMC article. Clinical Trial.
• Extended duration dual antiplatelet therapy and mortality: a systematic review and meta-analysis.

  Elmariah S, Mauri L, Doros G, Galper BZ, O'Neill KE, Steg PG, Kereiakes DJ, Yeh RW. Elmariah S, et al. Lancet. 2015 Feb 28;385(9970):792-8. doi: 10.1016/S0140-6736(14)62052-3. Epub 2014 Nov 16. Lancet. 2015. PMID: 25467565 Free PMC article.